Statins and diabetes: Are numbers tortured on JUPITER?

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 627-

  Mascitelli, Luca ^a   Goldstein, Mark R ^b  

^a Medical Service   (Italy)

^b NCH Healthcare Group   (United States)

Author keywords

Cardiovascular prevention; Cholesterol; Diabetes; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; ROSUVASTATIN;

CARDIOVASCULAR DISEASE; DEATH; DIABETES MELLITUS; HUMAN; LETTER; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SECONDARY PREVENTION; SURVIVAL RATE; VASCULAR DISEASE;

CARDIOVASCULAR PREVENTION; CHOLESTEROL; DIABETES; STATINS;

DIABETES MELLITUS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS AS TOPIC;

EID: 84883746236     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.195     Document Type: Article

References (8)

1. N. Sattar, D. Preiss, and H.M. Murray Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials Lancet 375 2010 735 742
2. L. Mascitelli, and M.R. Goldstein Long-standing statin therapy and the risk of new-onset diabetes in the elderly: collateral damage caused by preventive medicine? Drugs Aging 29 2012 9 13
3. L. Mascitelli, and M.R. Goldstein Statins, cholesterol depletion and risk of incident diabetes Int J Cardiol 152 2011 275 276
4. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
5. P.M. Ridker, A. Pradhan, J.G. MacFadyen, P. Libby, and R.J. Glynn Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial Lancet 380 2012 565 571
6. F.M. Sacks, M.A. Pfeffer, and L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
7. Cholesterol Treatment Trialists' (CTT) Collaborators The effect of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Lancet 380 2012 581 590
8. M. Bassan, and N. Panush Treating hypercholesterolemia - without the hype Am J Cardiol 79 1997 1001 1003